This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Hiromitsu Matsuzaki: Innovator in Thrombocytopoiesis
Introduction
Hiromitsu Matsuzaki is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medical science, particularly in the area of thrombocytopoiesis. His work has led to advancements that could potentially improve treatments for various blood-related conditions.
Latest Patents
Matsuzaki holds a patent for a thrombocytopoiesis stimulating factor. This innovation is crucial for enhancing the production of platelets, which play a vital role in blood clotting and overall health.
Career Highlights
Matsuzaki is associated with Chugai Pharmaceutical Co., Ltd., where he has been instrumental in research and development. His expertise in thrombocytopoiesis has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Matsuzaki has collaborated with esteemed colleagues such as Makoto Kawakita and Kiyoshi Takatsuki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hiromitsu Matsuzaki's contributions to thrombocytopoiesis and his work at Chugai Pharmaceutical Co., Ltd. highlight his importance in the field of medical innovation. His patent and collaborations reflect a commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile